Abstract
Since tumour spread involves numerous cell to cell and cell to matrix interactions it is expected that alterations in expression of cell adhesion receptors will play a significant role in modulating metastasis. Our interests have focused primarily upon the adhesion receptors involved in regulating the spread of malignant melanoma. Immunocytochemistry of clinical specimens has shown that the <i>α</i><sub>4</sub><i>β</i><sub>1</sub> integrin is expressed in melanoma but that this expression is restricted to metastases. We have identified two <i>α</i><sub>4</sub> deficient melanoma cell lines, HMB2 and VUP, which have had <i>α</i><sub>4</sub><i>β</i><sub>1</sub> expression reconstituted by infection with retroviruses carrying <i>α</i><sub>4</sub> cDNA. Such reconstituted VUP and HMB2 lines are able to bind to VCAM-1, an inducible endothelial cell adhesion molecule expressed on the surface of activated endothelium, and that such binding is inhibited with an <i>α</i><sub>4</sub> blocking antibody HP21. Binding of anti <i>α</i><sub>4</sub> antibody to the <i>α</i><sub>4</sub> expressing melanoma cell lines results in the induction of second messenger molecules, such as a calcium spike, and changes not only in adhesive but also in a migratory capacity. Thus, migration on VCAM-1 by human melanoma cells is <i>α</i><sub>4</sub><i>β</i><sub>1</sub> dependent suggesting that adhesion molecules expressed during tumor progression may play substantial roles in different steps of the metastatic process.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have